DOI: 10.1016/j.annemergmed.2016.11.025
,
,
PMID: 28110992
Issn Print: 0196-0644
Publication Date: 2017/05/01
Idarucizumab for the Reversal of Dabigatran
Michael Gottlieb; Basem Khishfe
Author Information: Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.